Re: Dutasteride plus Tamsulosin Fixed-Dose Combination First-Line Therapy versus Tamsulosin Monotherapy in the Treatment of Benign Prostatic Hyperplasia: A Budget Impact Analysis in the Greek Healthcare Setting Editorial Comment

被引：0
|
作者：
Kashyap, M. [1 ]
Belleville, S. [1 ]
Mulsant, B. H. [1 ]
Hilmer, S. Nl [1 ]
Paquette, A. [1 ]
Tu, L. M. [1 ]
Tannenbaum, C. [1 ]
机构：
[1] Univ Montreal, Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada
来源：
JOURNAL OF UROLOGY | 2015年 / 194卷 / 05期
关键词：
D O I：
10.1016/j.juro.2015.08.036
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1354 / 1355
页数：2
相关论文
共 42 条
  • [1] Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting
    Geitona, Maria
    Karabela, Pinelopi
    Katsoulis, Ioannis A.
    Kousoulakou, Hara
    Lyberopoulou, Eleni
    Bitros, Eleftherios
    Xaplanteris, Loukas
    Papanicolaou, Sotiria
    BMC UROLOGY, 2014, 14
  • [2] Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting
    Maria Geitona
    Pinelopi Karabela
    Ioannis A Katsoulis
    Hara Kousoulakou
    Eleni Lyberopoulou
    Eleftherios Bitros
    Loukas Xaplanteris
    Sotiria Papanicolaou
    BMC Urology, 14
  • [3] Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia
    Dimitropoulos, Konstantinos
    Gravas, Stavros
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (01) : 19 - 28
  • [4] Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada
    Sayani, Amyn
    Ismaila, Afisi
    Walker, Anna
    Posnett, John
    Laroche, Bruno
    Nickel, J. Curtis
    Su, Zhen
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (1-2): : E1 - E7
  • [5] A COST-UTILITY ANALYSIS OF DUTASTERIDE PLUS TAMSULOSIN COMBINATION THERAPY VERSUS TAMSULOSIN MONOTHERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN IRAN
    Peikanpour, M.
    Sharif, Z.
    Moghadam, Foroughi M. J.
    VALUE IN HEALTH, 2017, 20 (09) : A490 - A491
  • [6] BUDGET IMPACT ANALYSIS OF ADDING A NEW FIXED-DOSE COMBINATION THERAPY OF DUTASTERIDE AND TAMSULOSIN TO THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA IN QUEBEC, CANADA
    Ismaila, A.
    Posnett, J.
    Walker, A.
    Sayani, A.
    Robson, R. C.
    Su, Z.
    VALUE IN HEALTH, 2012, 15 (04) : A193 - A193
  • [7] DUTASTERIDE/TAMSULOSIN FIXED-DOSE COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC ENLARGEMENT
    Ismail, M.
    Hashim, H.
    DRUGS OF TODAY, 2012, 48 (01) : 17 - 24
  • [8] Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability
    Barkin, Jack
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 483 - 490
  • [9] Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
    Zhou, Zhongbao
    Cui, Yuanshan
    Wu, Jitao
    Ding, Rui
    Cai, Tong
    Gao, Zhenli
    BMC UROLOGY, 2019, 19 (1)
  • [10] Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
    Zhongbao Zhou
    Yuanshan Cui
    Jitao Wu
    Rui Ding
    Tong Cai
    Zhenli Gao
    BMC Urology, 19
12345